After a competitive, multiyear process to identify a home for the project, pharmaceutical giant Pfizer Inc. broke ground Tuesday on a research campus in Chesterfield, where it will hone development of medicine and vaccines.
The facility will both maintain and grow Pfizer’s local presence, retaining the company’s 450 current employees in the area while eventually creating 80 positions.
The 295,000 square feet of laboratory and office space represents a $236 million investment and is projected to be completed in mid-2019.
Company and government officials at Tuesday’s groundbreaking ceremony said that the region helped secure the project thanks to its established relationship with Pfizer and the strong pool of qualified expertise it offers in biological sciences.
Incentives from the state and St. Louis County were also offered to Pfizer through the Missouri Works Program. Those incentives could reach up to $5 million based on job creation totals.
Read more: St. Louis Post-Dispatch